FDA Investigator Lynda L Perry, PhD
Lynda L Perry, PhD has conducted inspections on 15 sites in 4 countries as of 24 Jun 2019. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
24 Jun 2019
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Germany,
Italy,
United States of America,
United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Lynda L Perry, PhD:
Abby M Miller,
Ademola O Daramola,
Alan P Kurtzberg,
Alexander M Kay,
Andrea A Branche,
Andrew E Kay,
Anita Narula, PhD,
Anthony C Warchut,
Antonina Aydanian,
Ashar P Parikh,
Astrida B Mattson,
Barbara Janine Breithaupt,
Bo Chi, PhD,
Bradley Dworak, PhD,
Bruce R Burrell,
Camille Bennett Hoffman,
Carl Lee,
Caryn M Mcnab,
CDR Rochelle B Young, RPh, MSA,
Charles M Edwards,
Christian D Lynch (CDL),
Christina V Santos,
Christine A Harman, PhD,
Christopher R Czajka,
Christopher T Middendorf,
Connie P Rezendes,
Cynthia J Lee, MS,
Cynthia Jim, CSO,
Dandan Wang, PhD,
Daniel J Roberts,
David M Beltran,
Dawn E Barkans,
Dell S Moller,
Dolores E Price,
Don H Bark, PhD,
Douglas C Kovacs,
Dr. Ralph M Bernstein, PhD,
Dr. Robert C Horan, MD,
Edwin Melendez,
Eileen A Liu,
Elva M Ibarra,
Emmanuel O Kerry,
Erica L Nicoll,
Estefania Fernandez,
Gerard Pde Leon,
Gloria J Baca, MS,
Gulshan R Anand,
Gwyn G Dickinson,
Heika R Bounds,
Heika R Tait,
Helen J Hamaoka,
Ingrid A Zambrana,
Ismael Garibay,
Jacqueline Mdiaz Albertini,
James C Lee, PharmD,
James C Maclaughlin,
James S Stuart, BS,
Jason K Morgan,
Jawaid Hamid,
Jazmine M Welcher,
Jeffrey M Watson,
Jen Sui,
Jennifer L Bridgewater,
Jennifer W Cheng Dobson,
Jinkee Mvila Binayug,
Joanne M Fukuda,
Joey V Quitania,
John A Gonzalez,
Jonathan T Little,
Jorge L Guadalupe,
Joseph Tibay,
June P Page,
Justin A Boyd,
Justine Tomasso,
Karen D Phung,
Karen J Bak,
Kari M Johansen,
Katherine L Arnold,
Kathryn A Krentz,
Kathryn E Ogger,
Keishla M Arroyo Lopez,
Kenneth H Williams,
Kenneth O Gee, PhD,
Kevin P Foley,
Kevin T Gerrity,
Kimberly Jproctor Jones,
Kristin M Abaonza,
Lance Mde Souza, MBA,
Larry K Austin,
Laurel A Beer,
LCDR Debra Emerson,
LCDR Jennifer H Rhyu,
Ligia M Sanders,
Lillian C Lopez,
Linda Thai,
Lisa A Bowden,
Lisa H Nakagawa,
Lisa K Capron,
LT Mark A Chen, MPH,
Lucila B Nwatu,
Madushini Dharmasena, PhD,
Marcus F Yambot,
Margaret M Annes,
Margo C Jones,
Maria Joselopez Barragan, PhD,
Maria Pkelly Doggett, MBA,
Marie B Buen Bigornia,
Marijo B Kambere, PhD,
Mariza M Jafary,
Mark C Saale,
Mark E Chan,
Mark W Babbitt,
Mary E Farbman, PhD,
Maxine H Wong,
Melanie M Walker,
Michelle Yclark Stuart,
Miguel A Martinez Perez,
Mihaly S Ligmond,
Mikel T Wright,
Mra B Kamberem,
Mra Davism,
Mra Munizn,
Nancy E Byerly,
Narahi J Alvarez Alcazar,
Omotunde O Osunsanmi,
Paula A Trost,
Peggy M Speight,
Peter C Chow,
Peter E Baker,
Prabhu P Raju,
Pratik S Upadhyay, DDC,
Ralph H Vocque,
Randy L Self,
Ravi S Harapanhalli,
Raymond T Oji,
Rebecca Rodriguez,
Reyes Candau Chacon, PhD,
Richard Ledwidge (nmi), PhD,
Riley C Myers, PhD,
Robert D Tollefsen,
Ronald P Boyce,
Rose Ashley,
Roy Baby,
S Lori Brown, PhD MPH,
Sandra S Saniga,
Sangeeta M Khurana, PhD,
Sangeeta M Rataul,
Scott R Nichols, PhD,
Sean Fitzsimmons,
Seneca D Toms,
Sharon K Thoma, PharmD,
Shuen G Chai,
Simone E Pitts,
Stephanie A Slater, MS,
Steven M Galvez,
Sunitha K Rajaram, PhD,
Susan F Laska, MS,
Susan M Jackson,
Susan T Hadman,
Tara A Marshall,
Tara L Greene,
Tara M Pianko,
Terri L Dodds,
Thomas C Mclean, CFS,
Thomas J Arista,
Thomas W Gordon,
Thuy T Nguyen, LCDR,
Tina S Roecklein,
Tracy K Li,
Travelle D Mason,
Uduak M Inokon,
Uttaniti Limchumroon (Tom),
Vilmary Negron Rodriguez,
Walden H Lee,
Wayne E Seifert,
William J Leonard,
Xiomara Copeland,
Yumi J Hiramine
Lynda L Perry, PhD's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2015 | FDA 483 | Partner Therapeutics, Inc. - Form 483, 2015-03-18 |
| November, 2016 | FDA 483 | Partner Therapeutics, Inc. - Form 483, 2016-11-18 |
| April, 2012 | FDA 483 | ALZA Corporation - Form 483, 2012-04-20 |
| May, 2014 | FDA 483 | Avara Liscate Pharmaceutical Services Spa - Form 483, 2014-05-13 |
| September, 2016 | FDA 483 | Jubilant HollisterStier LLC - Form 483, 2016-09-30 |
| May, 2013 | FDA 483 | Bayer Healthcare Pharmaceuticals, Inc - Form 483, 2013-05-24 |
| July, 2015 | EIR | Jubilant HollisterStier LLC - EIR, 2015-07-31 |
| July, 2015 | FDA 483 | Jubilant HollisterStier LLC - Form 483, 2015-07-31 |
| May, 2014 | EIR | Avara Liscate Pharmaceutical Services Spa - EIR, 2014-05-13 |
| July, 2015 | FDA 483 Response | Jubilant HollisterStier LLC - Form 483R, 2015-08-26 |
| June, 2016 | FDA 483 | Lonza Biologics, plc - Form 483, 2016-06-24 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more